Company focusing on development and commercialisation of innovative advanced wound care- medical systems, SANUWAVE Health (OTCMKTS:SNWV) on April 20, 2022, announced the patent activity for the last year.
On Wednesday, SNWV stock ended flat at $0.12 with 212K shares, compared to its average volume of 185K shares. The stock moved within a range of $0.1200 – 0.1200 after opening trade at $0.10.
SANUWAVE Health Announces Patent Activity from March 2021 to March 2022
The company said that shockwave technology has the following patents US 11,028,670 titled “Shock Wave Device with Far-Field Focused Reflectors”. Additionally, it has US 11,072,997 titled “Shock Waves for Oil Separation” covering methods and device embodiments applying shockwaves to separate substances, such as oil. Another patent is US 11,254,589, covering methods and device embodiments used for separating materials like foam, sludge, oil, or grease.
It also has KR 10-2255975 titled “Distributor Product Programming System”, a South Korean patent to control and monitor service activities by authorized SANUWAVE distributors globally. Furthermore, there is also EP 3285661 titled “Tissue Disinfection with Acoustic Pressure Shock Waves”, with a slew of countries covering methods and device embodiments harnessing extracorporeal acoustic pressure shock waves.
A total of sixteen new patents brings the total number of active patents for shockwave technology to 113, with seventy-five in the medical field while thirty-eight are in the non-medical field.
The acquisition of the UltraMIST assets in 2020 enables Sanuwave add the patents as well as applications related to the non-contact and low-frequency ultrasound technology. This portfolio encompasses constructions for combination systems, ultrasound systems, combination systems, drug delivery and methods for applying to ultrasound technology.
SNWV stock is trading below the 20-Day and 50-Day Moving averages of $0.13 and $0.15 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.14.